文献速递妇科

肥胖子宫内膜癌患者机器人手术与开腹手术后的长期生存

Long-term survival in obese patients after robotic or open surgery for endometrial cancer.
PubMed 文献 · Gynecol Oncol · 2020-06-09

研究纳入2006至2014年间接受初次手术的BMI≥30 kg/m²的子宫内膜癌肥胖女性217例,其中机器人手术131例、开腹手术86例。机器人组并发症(Clavien-Dindo II-V级)相对风险比为0.54(95%CI 0.31-0.93),估计失血量、手术时间和住院时间均显著更低。单变量生存曲线显示机器人组总生存(p=0.029)和相对生存(p=0.024)显著更优,无病生存无差异;多变量分析中机器人手术并非独立生存因素。

要点

  • 肥胖子宫内膜癌患者机器人手术较开腹手术并发症(Clavien-Dindo II-V级)相对风险比为0.54(95%CI 0.31-0.93)。
  • 机器人组5年相对生存率为96.2%(95%CI 89.7-103.3),开腹组为81.6%(95%CI 72.1-92.3)。
  • 多变量分析显示高危组织学是总生存(HR 2.90;95%CI 1.42-5.93;p<0.05)和无病生存(HR 2.74;95%CI 1.45-5.17;p<0.05)的独立危险因素。

核心结论

  • 肥胖子宫内膜癌患者机器人手术与开腹手术相比具有等效的长期生存和无病生存,且并发症显著更少、估计失血量更低、手术时间和住院时间更短。

研究设计与样本

  • 研究纳入2006至2014年间在机器人手术引入前后接受初次手术的BMI≥30 kg/m²的子宫内膜癌肥胖女性,共217例,其中机器人手术131例、开腹手术86例。
  • 通过国家癌症登记处和医疗档案获取并发症、生存和复发数据,计算总生存、相对生存和无病生存曲线,并采用Cox比例风险回归模型评估总生存和无病生存。

主要发现

  • 机器人组相比开腹组估计失血量、手术时间和住院时间显著更低。
  • 机器人组相比开腹组并发症(Clavien-Dindo II-V级)的相对风险比为0.54(95%CI 0.31-0.93)。
  • 单变量生存曲线(log rank检验)显示机器人组总生存(p=0.029)和相对生存(p=0.024)显著更优,无病生存无差异。
  • 机器人组5年相对生存率为96.2%(95%CI 89.7-103.3),开腹组为81.6%(95%CI 72.1-92.3)。
  • 多变量分析显示高危组织学是总生存(HR 2.90;95%CI 1.42-5.93;p<0.05)和无病生存(HR 2.74;95%CI 1.45-5.17;p<0.05)的独立危险因素,机器人手术并非生存的显著独立因素。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate surgical outcomes and survival after primary robotic or open surgery in obese women with endometrial cancer (EC). METHODS: The study included obese women (BMI ≥ 30 kg/m2) with EC who underwent primary surgery before and after the introduction of robotics between 2006 and 2014. Data on complications, survival, and recurrence was obtained through the National Cancer Registry and medical files. Survival curves were calculated for overall (OS), relative (RS) and disease-free survival (DFS). Cox proportional hazards regression models to assess OS and DFS. RESULTS: In total, 217 patients were identified, 131 robotic and 86 open surgical procedures. Significantly lower estimated blood loss, surgical time and hospital stay were found in the robotic group and the relative risk ratio of complications grades II-V, using the Clavien Dindo classification, was 0.54 (95% CI 0.31-0.93) for the robotic compared to the open group. A significant difference in OS (p = 0.029) and RS (p = 0.024) in favor of robotics was shown in the univariable survival curves, using log rank tests. No difference was seen for DFS. The 5-year RS was 96.2% (95% CI 89.7-103.3) for the robotic and 81.6% (95% CI 72.1-92.3) for the open group. Multivariable analysis showed high risk histology to be an independent risk factor, for both OS (HR 2.90; 95% CI 1.42-5.93; p < 0.05) and DFS (HR 2.74; 95% CI 1.45-5.17; p < 0.05). Robotic surgery was not found a significant independent factor for survival. CONCLUSIONS: Robotic surgery in obese women with EC had equivalent long-term and disease-free survival compared to open with significantly less complications, lower estimated blood loss, shorter surgical time and hospital stay.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Lindfors A, Heshar H, Adok C, et al. Long-term survival in obese patients after robotic or open surgery for endometrial cancer. Gynecol Oncol. 2020. PMID: 32527569. doi:10.1016/j.ygyno.2020.05.684

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。